Silibinin A API Manufacturers

compare suppliers & get competitive offers

Filters

Reset

Selected filters:

Type
Production region
Qualifications
Country of origin

Produced in:

China

Established in: 2019

MOQ: 1 kg

Employees: 10+

Focused on pharmaceutical industry

Reasonable price for the customers

Full service from R&D stage to commercial stage

  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • CoA

  • GMP

  • DMF

  • MSDS

Contact supplier

Replies quickly

Located in:

China
Contact supplier

Replies quickly

How does it work?

1
Register for free
icon

You can register for free as long as you are registering on behalf of a legal company related to the pharmaceutical industry

2
Start sourcing
icon

Search in the search bar the product that you’re looking for. We’ll show you an overview of all available suppliers. Use the filters to select the relevant suppliers only

3
Send inquiries
icon

Have you found interesting suppliers? Then it’s time to contact them. Use the send inquiry button and send them a message. You can send for each product, 3 inquiries per week

4
Get quotation
icon

Suppliers get notified by Pharmaoffer that they’ve received a new inquiry. They will come back to you with their questions, certificates, and offer in the chat on Pharmaoffer. We will send you an email in case of any news

5
Arrange agreement
icon

Does the supplier meet your quality and commercial requirements? Then you can place the order. Just follow the steps of our order module

Looking for Silibinin A API 22888-70-6?

Description:
Here you will find a list of producers, manufacturers and traders of Silibinin A. You can sort by certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
API | Excipient name:
Silibinin A 
Synonyms:
Silybin A , Silymarin I  
Cas Number:
22888-70-6 
DrugBank number:
DB09298 
Unique Ingredient Identifier:
33X338MNE4

About Silibinin A

You can find a short description about Silibinin here. Silibinin is the major active constituent of silymarin, a standardized extract of the milk thistle seeds, containing a mixture of flavonolignans consisting of silibinin, isosilibinin, silicristin, silidianin and others. Silibinin is presented as a mixture of two diastereomers, silybin A and silybin B, which are found in an approximately equimolar ratio. Both in vitro and animal research suggest that silibinin has hepatoprotective (antihepatotoxic) properties that protect liver cells against toxins.

Silibinin has also demonstrated in vitro anti-cancer effects against human prostate adenocarcinoma cells, estrogen-dependent and -independent human breast carcinoma cells, human ectocervical carcinoma cells, human colon cancer cells, and both small and nonsmall human lung carcinoma cells.

More information such as the structure, indication or toxicity is available on Drugbank, click the ID above.

Silibinin A is a type of Indifferent resources


Indifferent resources, in the context of pharmaceutical active pharmaceutical ingredients (APIs), refer to the subcategory of materials used in the manufacturing process that do not react with or significantly affect the chemical properties of the API. These resources play a crucial role in ensuring the purity and stability of the final pharmaceutical product.

Indifferent resources include solvents, excipients, catalysts, and other auxiliary substances used during API synthesis or formulation. They are carefully selected to have minimal reactivity with the API, preserving its chemical integrity and therapeutic efficacy. The choice of indifferent resources depends on factors such as the API's chemical structure, solubility, and stability requirements.

By employing indifferent resources, pharmaceutical manufacturers can mitigate the risk of unwanted chemical reactions or degradation during the production and storage of APIs. This, in turn, enhances the quality and reliability of the pharmaceutical product.

In the pharmaceutical industry, the selection and use of indifferent resources are critical in complying with regulatory guidelines and ensuring the safety and efficacy of medications. Manufacturers must adhere to Good Manufacturing Practices (GMP) and perform comprehensive compatibility studies to identify suitable indifferent resources for their specific APIs.

Overall, indifferent resources serve as indispensable components in the pharmaceutical API manufacturing process, guaranteeing the production of high-quality, stable, and safe medications that meet stringent regulatory standards.


Silibinin A (Indifferent resources), classified under Others


The others category refers to pharmaceutical APIs that do not fall under specific classifications such as antibiotics, antivirals, analgesics, or cardiovascular drugs. These APIs are diverse in nature and serve various therapeutic purposes, making them a crucial component of pharmaceutical formulations.

Pharmaceutical companies develop APIs in the others category to address specific medical conditions or target novel biological pathways. This category includes APIs used in oncology, neurology, immunology, and other specialized areas of medicine. The APIs in this category are often designed to interact with specific molecular targets or receptors, providing targeted therapeutic effects.

The development of APIs in the others category requires extensive research and testing to ensure their efficacy, safety, and compliance with regulatory standards. Pharmaceutical manufacturers employ advanced techniques such as chemical synthesis, biotechnology, and genetic engineering to produce these APIs.

Due to the broad range of applications and therapeutic uses, APIs in the others category contribute significantly to the advancement of medical treatments. Pharmaceutical companies constantly strive to innovate and discover new APIs within this category to address unmet medical needs and improve patient outcomes.

In conclusion, the others category of pharmaceutical APIs encompasses a diverse range of active ingredients used in drug formulation. These APIs play a crucial role in developing innovative therapies across various therapeutic areas, contributing to advancements in healthcare and patient well-being.



Silibinin A manufacturers | traders | suppliers

We have 2 companies offering Silibinin A produced in 1 different countries.

Get in contact with the supplier of your choice:

  • Apino Pharma Co., Ltd. from China, product country of origin China
  • Inner Mongolia Ever Brilliance Biotechnology Co., Ltd. from China, product country of origin China

Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.

You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.